Literature DB >> 20807070

The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward.

Tanya K Murphy1, Roger Kurlan, James Leckman.   

Abstract

Obsessive-compulsive disorder (OCD) and related conditions including Tourette's disorder (TD) are chronic, relapsing disorders of unknown etiology associated with marked impairment and disability. Associated immune dysfunction has been reported and debated in the literature since the late 80s. The immunologic culprit receiving the most interest has been Group A Streptococcus (GAS), which began to receive attention as a potential cause of neuropsychiatric symptoms, following the investigation of the symptoms reported in Sydenham's chorea (SC) and rheumatic fever, such as motor tics, vocal tics, and both obsessive-compulsive and attention deficit/hyperactivity symptoms. Young children have been described as having a sudden onset of these neuropsychiatric symptoms temporally associated with GAS, but without supporting evidence of rheumatic fever. This presentation of OCD and tics has been termed pediatric autoimmune neuropsychiatric disorders associated with Streptococcus (PANDAS). Of note, SC, OCD, and TD often begin in early childhood and share common anatomic areas--the basal ganglia of the brain and the related cortical and thalamic sites--adding support to the possibility that these disorders might share a common immunologic and/or genetic vulnerability. Relevant manuscripts were identified through searches of the PsycINFO and MedLine databases using the following keywords: OCD, immune, PANDAS, Sydenham chorea, Tourette's disorder Group A Streptococcus. Articles were also identified through reference lists from research articles and other materials on childhood OCD, PANDAS, and TD between 1966 and December 2010. Considering the overlap of clinical and neuroanatomic findings among these disorders, this review explores evidence regarding the immunobiology as well as the relevant clinical and therapeutic aspects of TD, OCD, and PANDAS.

Entities:  

Mesh:

Year:  2010        PMID: 20807070      PMCID: PMC4003464          DOI: 10.1089/cap.2010.0043

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  148 in total

1.  Antibasal ganglia antibodies and PANDAS.

Authors:  Davide Martino; Andrew J Church; Russell C Dale; Gavin Giovannoni
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

2.  Blood gene expression profiling of neurologic diseases: a pilot microarray study.

Authors:  Yang Tang; Donald L Gilbert; Tracy A Glauser; Andrew D Hershey; Frank R Sharp
Journal:  Arch Neurol       Date:  2005-02

3.  Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome.

Authors:  James F Leckman; Liliya Katsovich; Ivana Kawikova; Haiqun Lin; Heping Zhang; Holger Krönig; Syed Morshed; Salina Parveen; Heidi Grantz; Paul J Lombroso; Robert A King
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

4.  Quantification of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  Jose C Crispin; Araceli Martínez; Jorge Alcocer-Varela
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

5.  A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection.

Authors:  Kurt L Hoffman; Mady Hornig; Kavitha Yaddanapudi; Omar Jabado; W Ian Lipkin
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

Review 6.  Neuropsychological performance in obsessive-compulsive disorder: a critical review.

Authors:  Anne Katrin Kuelz; Fritz Hohagen; Ulrich Voderholzer
Journal:  Biol Psychol       Date:  2004-02       Impact factor: 3.251

7.  Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics.

Authors:  Tanya K Murphy; Muhammad Sajid; Ohel Soto; Nathan Shapira; Paula Edge; Mark Yang; Mark H Lewis; Wayne K Goodman
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

8.  The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician.

Authors:  Roger Kurlan; Edward L Kaplan
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

9.  Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection.

Authors:  Piero Pavone; Rio Bianchini; Enrico Parano; Gemma Incorpora; Renata Rizzo; Luigi Mazzone; Rosario R Trifiletti
Journal:  Pediatr Neurol       Date:  2004-02       Impact factor: 3.372

10.  Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.

Authors:  Giuseppe Matarese; Pietro Biagio Carrieri; Antonio La Cava; Francesco Perna; Veronica Sanna; Veronica De Rosa; Daniela Aufiero; Silvia Fontana; Serafino Zappacosta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

View more
  44 in total

1.  Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale.

Authors:  Eric A Storch; Alessandro S De Nadai; Adam B Lewin; Joseph F McGuire; Anna M Jones; P Jane Mutch; R Doug Shytle; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette's syndrome.

Authors:  Yuval Eliahu Landau; Tamar Steinberg; Brian Richmand; James Frederick Leckman; Alan Apter
Journal:  J Neural Transm (Vienna)       Date:  2011-12-03       Impact factor: 3.575

Review 3.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

4.  Anti-streptococcus IgM antibodies induce repetitive stereotyped movements: cell activation and co-localization with Fcα/μ receptors in the striatum and motor cortex.

Authors:  Danhui Zhang; Ankur Patel; Youhua Zhu; Allan Siegel; Steven S Zalcman
Journal:  Brain Behav Immun       Date:  2012-01-21       Impact factor: 7.217

5.  Streptococcal infection and immune response in children with Tourette's syndrome.

Authors:  Erzhen Li; Yiyan Ruan; Qian Chen; Xiaodai Cui; Lingyun Lv; Ping Zheng; Liwen Wang
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

Review 6.  Learning From Animal Models of Obsessive-Compulsive Disorder.

Authors:  Patricia Monteiro; Guoping Feng
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

7.  A pilot trial of cognitive-behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute-onset neuropsychiatric syndrome-related obsessive-compulsive disorder.

Authors:  Joshua M Nadeau; Cary Jordan; Robert R Selles; Monica S Wu; Morgan A King; Priyal D Patel; Camille E Hanks; Elysse B Arnold; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

Review 8.  Systematic review of proinflammatory cytokines in obsessive-compulsive disorder.

Authors:  Simon M Gray; Michael H Bloch
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 9.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

10.  Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells.

Authors:  Thamotharampillai Dileepan; Erica D Smith; Daniel Knowland; Martin Hsu; Maryann Platt; Peter Bittner-Eddy; Brenda Cohen; Peter Southern; Elizabeth Latimer; Earl Harley; Dritan Agalliu; P Patrick Cleary
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.